Headquarters
South Korea
Every company in the roster headquartered in South Korea.
Research
Compare company financial metrics
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
Views
39 of 39 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Yuhan Corporation000100 · KOSPI | 9 assets: 1 approved, 3 Ph 3, 2 Ph 2, 3 other | SarpogrelatePhase 3 · Atherosclerotic Cardiovascular DiseaseReliable signal | 31 Dec 2026Lazertinib · Phase 1 |
 Chong Kun Dang Pharmaceutical185750 · KOSPI | 7 assets: 2 Ph 3, 2 Ph 2, 3 Ph 1 | CKD-701Phase 3 · Age-Related Macular DegenerationReliable signal | 16 Nov 2026CKD-706 · Phase 1 |
 Dong-A ST170900 · KOSPI | 7 assets: 3 Ph 3, 2 Ph 2, 2 Ph 1 | EvogliptinPhase 3 · Type 2 DiabetesReliable signal | Dec 2026DA-2811 · Phase 2 |
 Daewoong Pharmaceutical069620 · KOSPI | 5 assets: 4 Ph 3, 1 Ph 1 | DWP16001Phase 3 · Type 2 DiabetesReliable signal | 27 Oct 2026DWRX5003 · Phase 1 |
 Hanmi Pharmaceutical128940 · KOSPI | 5 assets: 1 Ph 3, 3 Ph 2, 1 other | efpeglenatidePhase 3 · Type 2 DiabetesPartial signal | Jan 2027HM15275 · Phase 2 |
 JW Pharmaceutical001060 · KOSPI | 5 assets: 4 Ph 3, 1 Ph 2 | AnagliptinPhase 3 · Type 2 DiabetesReliable signal | 31 Mar 2027Anagliptin · Approved |
 AddpharmaPrivate | 4 assets: 1 Ph 3, 3 Ph 1 | AD-209Phase 3 · HypertensionPartial signal | None on record |
 LG Chem051910 · KOSPI | 4 assets: 1 Ph 3, 2 Ph 2, 1 Ph 1 | GemigliptinPhase 3 · Type 2 DiabetesReliable signal | Nov 2027LB-LR1109 · Phase 1 |
 HK inno.N Corporation195940 · KOSDAQ | 3 assets: 2 Ph 3, 1 Ph 2 | CJ-30060Phase 3 · HypertensionPartial signal | None on record |
 AJU PharmPrivate | 2 assets: 2 Ph 3 | AJU-A51Phase 3 · Type 2 DiabetesPartial signal | None on record |
 Ahn-Gook Pharmaceutical001540 · KOSDAQ | 2 assets: 2 Ph 3 | AG2304RPhase 3 · Atherosclerotic Cardiovascular DiseasePartial signal | None on record |
 Curacle365270 · KOSDAQ | 2 assets: 2 Ph 2 | CU104Phase 2 · Ulcerative ColitisPartial signal | None on record |
 GlaceumPrivate | 2 assets: 2 Ph 2 | HSG4112Phase 2 · ObesityPartial signal | None on record |
| 1 asset: 1 Ph 1 | ADEL-Y01Phase 1 · Alzheimer's DiseasePartial signal | None on record | |
 Anterogen065660 · KOSDAQ | 1 asset: 1 Ph 3 | Cupistem / ALLO-ASCPhase 3 · Crohn's DiseaseWeak signal | None on record |
 Aptabio Therapeutics293780 · KOSDAQ | 1 asset: 1 Ph 2 | APX-115Phase 2 · Type 2 DiabetesPartial signal | 30 Jun 2027APX-115 · Phase 2 |
 AriBioPrivate | 1 asset: 1 Ph 3 | AR1001Phase 3 · Alzheimer's DiseasePartial signal | None on record |
 BeyondBioPrivate | 1 asset: 1 Ph 2 | BEY2153Phase 2 · Alzheimer's DiseasePartial signal | Jul 2028BEY2153 · Phase 2 |
 BnH Research (Korea)Private | 1 asset: 1 Ph 1 | BnH-015BPhase 1 · Alzheimer's Disease | None on record |
 Boryung Pharmaceutical003850 · KOSPI | 1 asset: 1 Ph 3 | BR1017Phase 3 · Atherosclerotic Cardiovascular DiseasePartial signal | None on record |
 CKD Bio CorporationPrivate | 1 asset: 1 other | L. lactis CKDB001Alzheimer's Disease | 31 May 2027L. lactis CKDB001 · Phase na |
 G2GBio, Inc.Private | 1 asset: 1 Ph 1 | GB-5001Phase 1 · Alzheimer's DiseaseWeak signal | None on record |
 GemVax & KAEL082270 · KOSDAQ | 1 asset: 1 Ph 3 | GV1001Phase 3 · Alzheimer's DiseasePartial signal | None on record |
 Huons084110 · KOSDAQ | 1 asset: 1 Ph 1 | HUC2-676Phase 1 · Obesity | None on record |
 Innovo TherapeuticsPrivate | 1 asset: 1 Ph 1 | INV-101Phase 1 · Ulcerative ColitisPartial signal | None on record |
 IntoCell, Inc287840 · KOSDAQ | 1 asset: 1 Ph 1 | ITC-6146ROPhase 1 · Non-Small Cell Lung Cancer | 30 Jun 2027ITC-6146RO · Phase 1 |
 J Ints BioPrivate | 1 asset: 1 Ph 2 | JIN-A02Phase 1/2 · Non-Small Cell Lung Cancer | None on record |
 Jeil PharmaceuticalPrivate | 1 asset: 1 Ph 3 | JT-001Phase 3 · Type 2 DiabetesReliable signal | None on record |
 Kangstem Biotech217730 · KOSDAQ | 1 asset: 1 Ph 3 | Furestem-CDPhase 3 · Crohn's DiseaseWeak signal | None on record |
 LigaChem Biosciences, Inc.141080 · KOSDAQ | 1 asset: 1 Ph 2 | LCB84Phase 1/2 · Non-Small Cell Lung Cancer | Jan 2027LCB84 · Phase 1/2 |
 Lmito TherapeuticsPrivate | 1 asset: 1 Ph 1 | LMT503Phase 1 · Ulcerative Colitis | 1 Sep 2027LMT503 · Phase 1 |
| 1 asset: 1 Ph 3 | PM012Phase 2/3 · Alzheimer's DiseasePartial signal | None on record | |
 NEUROBiOGENPrivate | 1 asset: 1 Ph 2 | KDS2010Phase 2 · Alzheimer's Disease | 31 Jan 2027KDS2010 · Phase 2 |
 Nature Cell Co., Ltd.007390 · KOSDAQ | 1 asset: 1 Ph 2 | AstroStemPhase 2 · Alzheimer's DiseasePartial signal | None on record |
 Peptron087010 · KOSDAQ | 1 asset: 1 Ph 2 | PT320Phase 2 · Parkinson's DiseasePartial signal | None on record |
PharmacobioPrivate | 1 asset: 1 Ph 1 | DDN-A-0101Phase 1 · Alzheimer's DiseasePartial signal | None on record |
 ProGen296160 · KONEX | 1 asset: 1 Ph 2 | PG-102Phase 2 · ObesityPartial signal | 1 Dec 2026PG-102 · Phase 1 |
 Twinpig Biolab, Inc.Private | 1 asset: 1 Ph 2 | TB511Phase 1/2 · Non-Small Cell Lung Cancer | Mar 2027TB511 · Phase 1/2 |
 VTBIO Co. Ltd (South Korea)Private | 1 asset: 1 Ph 1 | VT301Phase 1 · Alzheimer's DiseaseWeak signal | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).